{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:48:23Z","timestamp":1694634503509},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1157\/13073789","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T17:28:44Z","timestamp":1231262924000},"page":"185-190","source":"Crossref","is-referenced-by-count":1,"title":["pS2 citos\u00f3lica y proliferaci\u00f3n celular en carcinomas ductales infiltrantes de mama hormonodependientes"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"S\u00e1nchez Salm\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Argibay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruibal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13073789_bib1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000478-199809000-00012","article-title":"Primary mucinous carcinomas of the skin express TFF1, TFF3, estrogen receptor and progesterone receptors","volume":"22","author":"Hanby","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1157\/13073789_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<554::AID-PATH557>3.0.CO;2-V","article-title":"Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors","volume":"190","author":"Saegusa","year":"2000","journal-title":"J Pathol"},{"key":"10.1157\/13073789_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0212-6982(02)72044-2","article-title":"La pS2 citos\u00f3lica en 154 carcinomas no microc\u00edticos de pulm\u00f3n. Correlaci\u00f3n con otros par\u00e1metros cl\u00ednico-biol\u00f3gicos","volume":"21","author":"Ruibal","year":"2002","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13073789_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/172460080301800409","article-title":"Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1\/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors","volume":"18","author":"Vizoso","year":"2003","journal-title":"Int J Biol Markers"},{"key":"10.1157\/13073789_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1096\/fj.01-0498fje","article-title":"The estrogen regulated protein, TFF1, stimulates migration of human breast cancer cells","volume":"16","author":"Prest","year":"2002","journal-title":"FASEB J"},{"key":"10.1157\/13073789_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbrc.2003.07.001","article-title":"Estrogen \u2013induced genes, WISP-2 and pS2, respond divergently to proteinkinase pathway","volume":"309","author":"Inadera","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1157\/13073789_bib7","first-page":"6755","article-title":"Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors","volume":"61","author":"Lu","year":"2001","journal-title":"Cancer Res"},{"key":"10.1157\/13073789_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0212-6982(02)72029-6","article-title":"An\u00e1lisis del contenido citos\u00f3lico de pS2 en c\u00e1ncer de mama","volume":"21","author":"Tamargo","year":"2002","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13073789_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-9776(02)00290-4","article-title":"Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer","volume":"12","author":"Ioachim","year":"2003","journal-title":"Breast"},{"key":"10.1157\/13073789_bib10","first-page":"84","article-title":"Diferencias cl\u00ednico-biol\u00f3gicas entre carcinomas ductal infiltrante y lobulillar infiltrante. Resultados preliminares","volume":"18","author":"Ruibal","year":"1999","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13073789_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0212-6982(01)72007-1","article-title":"Carcinomas ductales infiltrantes de mama en mujeres mayores de 60 a\u00f1os. Asociaci\u00f3n con alta proliferaci\u00f3n celular y menores concentraciones de pS2 y \u00e1cido hialur\u00f3nico citos\u00f3lico y en la membrana celular","volume":"20","author":"Ruibal","year":"2001","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13073789_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1054\/brst.2000.0223","article-title":"Evaluation of prognostic factors in male breast cancer","volume":"10","author":"Temmin","year":"2001","journal-title":"Breast"},{"key":"10.1157\/13073789_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1006215310169","article-title":"pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers","volume":"56","author":"Gillesby","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1157\/13073789_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-8981(95)06247-5","article-title":"Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification","volume":"247","author":"Bolufer","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1157\/13073789_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/028418699432978","article-title":"Immunoradiometric measurement of pS2 in breast cancer\u2013correlation with steroid receptors and plasminogen activators","volume":"38","author":"Luqmani","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1157\/13073789_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W","article-title":"Estrogen receptor (ER) and progesterone receptor (PgR), by ligand \u2013binding assay compared with ER, PgR and pS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: a southwest oncology group study","volume":"89","author":"Elledge","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1157\/13073789_bib17","first-page":"143","article-title":"Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen \u2013dependent protein in cells of mammary ductal carcinoma. Analysis of five course of the disease","volume":"39","author":"Surowiak","year":"2001","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1157\/13073789_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/172460089901400311","article-title":"pS2 negativity in postmenopausal women with ER + PgR + infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors","volume":"14","author":"Ruibal","year":"1999","journal-title":"Int J Biol Markers"},{"key":"10.1157\/13073789_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0212-6982(00)71905-7","article-title":"Impacto cl\u00ednico-biol\u00f3gico de la positividad para la pS2 en carcinomas ductales infiltrantes de mama receptor de estr\u00f3genos negativos","volume":"19","author":"Ruibal","year":"2000","journal-title":"Rev Esp Med Nucl"},{"key":"10.1157\/13073789_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2184.1999.32230107.x","article-title":"Association of pS2 (TFF1) release with breast tumor proliferative rate: in vitro and in vivo studies","volume":"32","author":"Reshkin","year":"1999","journal-title":"Cell Prolif"},{"key":"10.1157\/13073789_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0002-9440(10)61687-2","article-title":"High expression of the trefoil TFF1 in interval breast cancers","volume":"159","author":"Crosier","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1157\/13073789_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/172460080101600108","article-title":"Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients","volume":"16","author":"Ruibal","year":"2001","journal-title":"Int J Biol Markers"},{"key":"10.1157\/13073789_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/172460080301800306","article-title":"Cytosolic neuron specific enolase levels in squamous carcinomas of the lung","volume":"18","author":"Ruibal","year":"2003","journal-title":"Int J Biol Markers"},{"key":"10.1157\/13073789_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<4::AID-PATH1099>3.0.CO;2-5","article-title":"Trefoil proteins: their role in normal and malignant cells","volume":"183","author":"May","year":"1997","journal-title":"J Pathol"},{"key":"10.1157\/13073789_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-0760(00)00119-9","article-title":"Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells","volume":"74","author":"Kim","year":"2000","journal-title":"J Syteroid Biochem Mol Biol"},{"key":"10.1157\/13073789_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/bchm.1998.379.4-5.409","article-title":"The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein","volume":"379","author":"Martin","year":"1998","journal-title":"Biol Chem"},{"key":"10.1157\/13073789_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K","article-title":"Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolitic polypeptide (TFF2) mRNAs are co-expressed in normal, hyperplastic and neoplastic human breast epithelium","volume":"183","author":"Poulson","year":"1997","journal-title":"J Pathol"},{"key":"10.1157\/13073789_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bj3270117","article-title":"Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR\/pS2 though cysteine 58","volume":"327","author":"Chadwick","year":"1997","journal-title":"Biochem J"},{"key":"10.1157\/13073789_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF02303669","article-title":"Expression of pS2, c-erbB2, and cathepsin D during the menstrual cycle in human breast cancers","volume":"4","author":"Khan","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1157\/13073789_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000227729","article-title":"Effect of tamoxifen on pS2 expression in human breast cancers","volume":"54","author":"Motomura","year":"1997","journal-title":"Oncology"},{"key":"10.1157\/13073789_bib31","first-page":"2877","article-title":"pS2 expression in BRCA1-associated breast cancers","volume":"21","author":"Charafe-Jauffre","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1157\/13073789_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/gcc.10321","article-title":"Germ-line mutations in BRCA11 or BRCA2 in the normal breast are associated with altered expression of estrogen \u2013responsive proteins and the predominance of progesterone receptor A","volume":"39","author":"Mote","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1157\/13073789_bib33","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1158\/1078-0432.CCR-03-0141","article-title":"Breast cancer patients witrh progesterone receptor PR-A-rich tumors have poorer disease-free survival rates","volume":"10","author":"Hopp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13073789_bib34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","article-title":"Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999","volume":"124","author":"Fitzgibbons","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1157\/13073789_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1006262501062","article-title":"Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines","volume":"56","author":"Tong","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1157\/13073789_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3835(99)00178-0","article-title":"Biphasic scatchard plots of oestrogen receptors are associated with low pS2 levels in human breast cancers","volume":"144","author":"Marsigliante","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1157\/13073789_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0025-7753(02)73573-2","article-title":"Diferencias cl\u00ednico-biol\u00f3gicas entre carcinomas ductales infiltrantes de mama en mujeres mayores de 70 a\u00f1os y entre 60 y 70","volume":"119","author":"Ruibal","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13073789_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0049-3848(93)90046-Q","article-title":"Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer","volume":"69","author":"Rella","year":"1993","journal-title":"Thromb Res"},{"key":"10.1157\/13073789_bib39","first-page":"955","article-title":"Estrogen-induced genes in breast cancer, and their medical importance","volume":"183","author":"Rochefort","year":"1999","journal-title":"Bull Acad Natl Med"},{"key":"10.1157\/13073789_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2303.1997.44175441.x","article-title":"DNA ploidy and pS2 protein expression in breast cancer","volume":"8","author":"Ioakin-Liossi","year":"1997","journal-title":"Cytopathology"},{"key":"10.1157\/13073789_bib41","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.11209","article-title":"Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance","volume":"97","author":"Michels","year":"2003","journal-title":"Cancer"},{"key":"10.1157\/13073789_bib42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ijc.2910570610","article-title":"Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S.-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry","volume":"57","author":"Gasparini","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1157\/13073789_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cncr.11916","article-title":"Proliferative activity in primary breast carcinomas is a salient prognostic factor","volume":"100","author":"Michels","year":"2004","journal-title":"Cancer"},{"key":"10.1157\/13073789_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cyto.b.10040","article-title":"Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy","volume":"55B","author":"Michels","year":"2003","journal-title":"Cytometry"},{"key":"10.1157\/13073789_bib45","first-page":"577","article-title":"pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer","volume":"18","author":"Jansen","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1157\/13073789_bib46","first-page":"5","article-title":"Prognostic significance of the estrogen-regulated proteins, cathepsin D and pS2 in breast cancer","volume":"89","author":"Fulco","year":"1998","journal-title":"Minerva Med"},{"key":"10.1157\/13073789_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/bjc.1998.78","article-title":"pS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer","volume":"77","author":"Thopmson","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1157\/13073789_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/172460089801300106","article-title":"Impact of steroid receptors, pS2 and cathepsin D on the outcome of N + postmenopausal breast cancer patients treated with tamoxifen","volume":"13","author":"Dittadi","year":"1998","journal-title":"Int J Biol Markers"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698205741550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698205741550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T13:37:59Z","timestamp":1632922679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698205741550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0212698205741550"],"URL":"https:\/\/doi.org\/10.1157\/13073789","relation":{},"ISSN":["0212-6982"],"issn-type":[{"value":"0212-6982","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}